Cardiovascular Outcomes in Individuals With Diabetes, Coronary Heart Disease, or Both: A Population-Based Cohort

Kevin K W Olesen1, Christine Gyldenkerne1, Pernille G Thrane1

  • 1Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Insights

In contemporary cohorts, diabetes alone presents a lower cardiovascular risk than coronary heart disease (CHD) alone. However, diabetes increases non-coronary vascular events and all-cause mortality, highlighting its significant long-term health impact.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Historically, diabetes conferred cardiovascular risk comparable to prior myocardial infarction.
  • The advent of statins introduced new primary preventive strategies.
  • Contemporary risk stratification for diabetes and coronary heart disease (CHD) requires re-evaluation.

Purpose of the Study:

  • To compare the cardiovascular risk associated with diabetes alone versus CHD alone in a contemporary population.
  • To assess the impact of these conditions on major adverse cardiovascular events, coronary events, non-coronary vascular events, and all-cause mortality.

Main Methods:

  • A cohort of 1,116,456 individuals aged 50-89 in Western Denmark (January 1, 2012) was analyzed.
  • Participants were categorized into four groups: diabetes alone, CHD alone, both, or neither.
  • Follow-up was conducted for up to seven years to record cardiovascular outcomes.

Main Results:

  • Diabetes alone showed lower seven-year rates of MACE (10.8% vs. 19.7%) and coronary events (6.1% vs. 16.0%) compared to CHD alone.
  • Diabetes alone was associated with higher rates of non-coronary vascular events (9.4% vs. 9.9%) and all-cause mortality (25.6% vs. 30.6%).

Conclusions:

  • Diabetes alone does not present the same level of coronary or cardiovascular risk as CHD alone in the contemporary era.
  • Diabetes is linked to increased risks of non-coronary vascular events and all-cause mortality, necessitating targeted preventive strategies.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...